Lsv Asset Management Abb Vie Inc. Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

A detailed history of Lsv Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Lsv Asset Management holds 14,000 shares of ABBV stock, worth $2.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,000

Previous 594,470 97.64%

Holding current value

$2.31 Million

Previous $102 Million 97.29%

% of portfolio

0.01%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $95.1 Million - $116 Million	-580,470 Reduced 97.64%	14,000 $2.77 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $5.39 Million - $6.29 Million	-34,800 Reduced 5.53%	594,470 $102 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $6.27 Million - $7.14 Million	-39,220 Reduced 5.87%	629,270 $115 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $14.5 Million - $16.3 Million	-105,400 Reduced 13.62%	668,490 $104 Million
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $3.96 Million - $4.59 Million	-29,680 Reduced 3.69%	773,890 $115 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $86.9 Million - $108 Million	-655,510 Reduced 44.93%	803,570 $108 Million
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $41.1 Million - $47.3 Million	-283,960 Reduced 16.29%	1,459,080 $233 Million
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $140 Million - $168 Million	-1,014,922 Reduced 36.8%	1,743,040 $282 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $14.8 Million - $16.9 Million	-109,956 Reduced 3.83%	2,757,962 $370 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $57.6 Million - $73.2 Million	-418,514 Reduced 12.73%	2,867,918 $439 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $6.57 Million - $8.15 Million	-49,759 Reduced 1.49%	3,286,432 $533 Million
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $7.92 Million - $10 Million	-73,700 Reduced 2.16%	3,336,191 $452 Million
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $15.9 Million - $18.1 Million	149,903 Added 4.6%	3,409,891 $368 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $6.13 Million - $6.83 Million	58,287 Added 1.82%	3,259,988 $367 Million
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $26.4 Million - $29 Million	-257,673 Reduced 7.45%	3,201,701 $346 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $20.5 Million - $27.7 Million	-254,500 Reduced 6.85%	3,459,374 $371 Million
Q3 2020 Oct 23, 2020	SELL	$85.91 - $100.83 $4.99 Million - $5.86 Million	-58,099 Reduced 1.54%	3,713,874 $325 Million
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $130 Million - $174 Million	-1,773,550 Reduced 31.98%	3,771,973 $370 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $22.4 Million - $34 Million	-347,664 Reduced 5.9%	5,545,523 $423 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $10.5 Million - $13.2 Million	-145,863 Reduced 2.42%	5,893,187 $522 Million
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $29.3 Million - $35.3 Million	-465,876 Reduced 7.16%	6,039,050 $457 Million
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $5.48 Million - $7.01 Million	83,454 Added 1.3%	6,504,926 $473 Million
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $12.1 Million - $14.3 Million	157,043 Added 2.51%	6,421,472 $518 Million
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $1.28 Million - $1.58 Million	-16,418 Reduced 0.26%	6,264,429 $578 Million
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $12.5 Million - $13.9 Million	140,560 Added 2.29%	6,280,847 $594 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $537,243 - $635,680	5,984 Added 0.1%	6,140,287 $569 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $17 Million - $22.8 Million	-185,000 Reduced 2.93%	6,134,303 $581 Million
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $46.9 Million - $51.4 Million	-523,470 Reduced 7.65%	6,319,303 $0
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $478 Million - $611 Million	6,842,773	6,842,773 $608 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Abb Vie Inc. Transaction History